Loading organizations...
§ Private Profile · Foster City, CA, USA
Biopharmaceutical company developing targeted drugs for liver disease and c
Terns Pharmaceuticals has raised $167.0M across 2 funding rounds.
Terns Pharmaceuticals has raised $167.0M in total across 2 funding rounds.
Terns Pharmaceuticals has raised $167.0M across 2 funding rounds. Most recently, it raised $87.0M Series C in January 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 5, 2021 | $87M Series C | Elise Wang | ELI Lilly And Company, Lilly Asia Ventures, OrbiMed, Samsara BioCapital, Suvretta Capital Management, Vivo Capital | Announced |
| Oct 30, 2018 | $80M Series B | Carl Gordon, Vivo Capital | Decheng Capital, Lilly Asia Ventures | Announced |
Terns Pharmaceuticals has raised $167.0M in total across 2 funding rounds.
Terns Pharmaceuticals's investors include Elise Wang, Eli Lilly and Company, Lilly Asia Ventures, OrbiMed, Samsara BioCapital, Suvretta Capital Management, Vivo Capital, Carl Gordon, Decheng Capital.